Her primary areas of study are Internal medicine, Immunology, Gastroenterology, Inflammation and Endocrinology. She is studying Bone density, which is a component of Internal medicine. Grace A. McComsey has included themes like Tunica intima, Subclinical infection and Acquired immunodeficiency syndrome in her Immunology study.
As a member of one scientific family, Grace A. McComsey mostly works in the field of Gastroenterology, focusing on Lipodystrophy and, on occasion, Viral load. Her Inflammation research is multidisciplinary, relying on both CD8 and Monocyte. Grace A. McComsey combines subjects such as Placebo and Systemic inflammation with her study of Endocrinology.
The scientist’s investigation covers issues in Internal medicine, Immunology, Gastroenterology, Inflammation and Endocrinology. Her research on Internal medicine frequently connects to adjacent areas such as Placebo. Her Immunology research integrates issues from Mitochondrial toxicity, Acquired immunodeficiency syndrome and Disease.
Her Gastroenterology research incorporates elements of Interquartile range, Fibrinogen, Ritonavir, Raltegravir and Cohort. The Inflammation study which covers Monocyte that intersects with CD14. She interconnects Lipodystrophy and Lipoatrophy in the investigation of issues within Endocrinology.
Her primary areas of study are Internal medicine, Gastroenterology, Inflammation, Insulin resistance and Immunology. Her work in Internal medicine addresses issues such as Cardiology, which are connected to fields such as Diastole. The study incorporates disciplines such as Interquartile range, Statin, Rosuvastatin, Serum albumin and Intima-media thickness in addition to Gastroenterology.
Her Inflammation study combines topics from a wide range of disciplines, such as Biomarker, Immune system, Physiology and Antiretroviral therapy. The various areas that she examines in her Insulin resistance study include Adipose tissue and Raltegravir. Many of her research projects under Immunology are closely connected to CD38 with CD38, tying the diverse disciplines of science together.
Grace A. McComsey spends much of her time researching Internal medicine, Inflammation, Immunology, Chromosomal translocation and Zonulin. Her Internal medicine study focuses on Mass index in particular. Her research integrates issues of Zidovudine, Immunophenotyping, CD14, Monocyte and Physiology in her study of Inflammation.
The Chromosomal translocation study combines topics in areas such as Immune activation, Gastrointestinal Microbiome, Intestinal permeability, Lipopolysaccharide binding protein and Systemic inflammation. Her studies in Zonulin integrate themes in fields like Interleukin 6, Viral load, Reverse-transcriptase inhibitor and Breast feeding. Her research investigates the connection with Darunavir and areas like Endocrinology which intersect with concerns in Atazanavir and Emtricitabine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
Grace A. McComsey;Douglas Kitch;Eric S. Daar;Camlin Tierney.
The Journal of Infectious Diseases (2011)
Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers
Grace A. McComsey;Pablo Tebas;Elizabeth Shane;Michael T. Yin.
Clinical Infectious Diseases (2010)
Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen
Todd T Brown;Grace A McComsey;Martin S King;Roula B Qaqish.
Journal of Acquired Immune Deficiency Syndromes (2009)
Immunologic Failure Despite Suppressive Antiretroviral Therapy Is Related to Activation and Turnover of Memory CD4 Cells
Michael M. Lederman;Leonard Calabrese;Nicholas T. Funderburg;Brian Clagett.
The Journal of Infectious Diseases (2011)
Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials
Paul E. Sax;Kristine M. Erlandson;Jordan E. Lake;Grace A. McComsey.
Clinical Infectious Diseases (2020)
Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1: A Randomized, Controlled Equivalence Trial
Jeffrey L. Lennox;Raphael J. Landovitz;Heather J. Ribaudo;Ighovwerha Ofotokun.
Annals of Internal Medicine (2014)
Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima-Media Thickness in HIV-Infected Patients Receiving Antiretroviral Therapy
Allison C. Ross;Nesrine Rizk;Mary Ann O'Riordan;Vikram Dogra.
Clinical Infectious Diseases (2009)
Improvement in Lipoatrophy Associated with Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus—Infected Patients Switched from Stavudine to Abacavir or Zidovudine: The Results of the TARHEEL Study
Grace A. McComsey;Douglas J. Ward;Siegrid M. Hessenthaler;Michael G. Sension.
Clinical Infectious Diseases (2004)
Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy
Todd T. Brown;Katherine Tassiopoulos;Ronald J. Bosch;Cecilia Shikuma.
Diabetes Care (2010)
Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D.
Todd T Brown;Grace A McComsey.
Antiviral Therapy (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: